title: Right ventricular function at rest and during exercise in chronic obstructive pulmonary disease.
abstract: Right ventricular ejection fraction (RVEF), a measure of systolic pump performance of the right ventricle, is frequently depressed at rest or during exercise in patients with chronic obstructive pulmonary disease (COPD). The most common cause of reduced RVEF in COPD is augmentation of right ventricular afterload, namely an increase in pulmonary artery pressure and pulmonary vascular resistance. Therapy with agents that decrease the afterload on the right ventricle have the potential to improve the systolic performance of this chamber. Oxygen, vasodilators such as hydralazine and nifedipine, theophylline, and sympathomimetics all may augment RVEF in part by reducing pulmonary vascular resistance and, in some cases, pulmonary artery pressures in patients with COPD and cor pulmonale. However, only oxygen therapy has been shown to improve survival.
authors.affiliation: Yale University School of Medicine, New Haven, Conn.
authors.forename: R A
authors.initials: RA
authors.lastname: Matthay
authors.forename: A C
authors.initials: AC
authors.lastname: Arroliga
authors.forename: H P
authors.initials: HP
authors.lastname: Wiedemann
authors.forename: D S
authors.initials: DS
authors.lastname: Schulman
authors.forename: D A
authors.initials: DA
authors.lastname: Mahler
mesh_terms: D004070:Digitalis; D015444:Exercise / Q000502:physiology*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000503:physiopathology* / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012016:Reference Values; D012146:Rest / Q000502:physiology*; D013566:Sympathomimetics / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D016276:Ventricular Function; D016278:Ventricular Function, Right / Q000502:physiology*
chemical_list: D013566:Sympathomimetics; D014665:Vasodilator Agents; D013806:Theophylline